GI360™ and Stool Testing Q&A with Regenerus and Doctor’s Data

This video is a Q&A session featuring Dr. Malkowski and Paula from Regenerus Labs, discussing the GI360™ stool test by Doctor's Data. They cover key aspects of the test, including microbiome diversity, dysbiosis, functional markers, testing methodologies (PCR, culture, microscopy), pathogen identification, and clinical applications. They also address commonly asked questions from practitioners to help improve interpretation and clinical use of the GI360™ report.

CHAPTERS:
00:00 Welcome & Event Overview
01:51 Microbiome Diversity vs. Dysbiosis
04:22 Selecting Bacteria for GI 360
06:06 Research Supporting GI 360 Bacteria
07:46 Why Some Bacteria Are Excluded
08:42 Functional Markers and Report Layout
10:09 Pathogens and Inflammatory Markers
11:26 Microscopy and Yeast Detection
13:17 PCR, Microscopy & Culture Explained
16:07 PCR vs. Shotgun Sequencing
17:34 Value of Inflammatory Markers
19:24 Susceptibility Testing Explained
21:11 Individualized Antimicrobial Guidance
22:43 Limitations of Susceptibility Coverage
24:57 Blood Markers: RBC vs. Occult
25:46 Pollen Significance in Stool Testing
27:00 PCR and Historical Infections
28:15 Mucus in Stool Samples
29:49 Why H. pylori & Zonulin Are Optional
31:09 Assessing Gut Barrier & Flora Function
32:00 Can GI 360 Indicate SIBO?
33:20 Final Thoughts & Upcoming Masterclass